![Othon Gervasio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Othon Gervasio is currently working as the Chief Medical Officer at Clarity Pharmaceuticals Ltd. He previously worked as the Medical Director at Novartis Pharmaceuticals Australia Pty Ltd.
| Sociétés | Poste | Début |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Directeur Technique/Scientifique/R&D | 26/08/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharmaceuticals Australia Pty Ltd.
 Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 2 |
|---|---|
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Health Technology |
Clarity Pharmaceuticals Ltd.
 Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
